Parallel Advisors, LLC Reata Pharmaceuticals Inc Transaction History

Parallel Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$30.85 - $93.17 $771 - $2,329	25 New	25 $2,000
Q1 2023 Apr 25, 2023	BUY	$30.85 - $93.17 $771 - $2,329	25 New	25 $2,000
Q1 2022 Apr 28, 2022	SELL	$24.12 - $39.6 $72 - $118	-3 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$25.61 - $110.96 $2,125 - $9,209	-83 Reduced 96.51%	3 $0
Q3 2021 Nov 02, 2021	BUY	$100.0 - $143.02 $4,200 - $6,006	42 Added 95.45%	86 $9,000
Q2 2021 Aug 06, 2021	SELL	$78.27 - $151.29 $2,426 - $4,689	-31 Reduced 41.33%	44 $6,000
Q1 2021 Apr 23, 2021	BUY	$94.25 - $132.81 $6,409 - $9,031	68 Added 971.43%	75 $7,000
Q3 2020 Oct 27, 2020	SELL	$93.53 - $163.34 $561 - $980	-6 Reduced 46.15%	7 $1,000
Q2 2020 Jul 16, 2020	BUY	$126.3 - $176.56 $1,641 - $2,295	13 New	13 $2,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.